Pfizer Vaccine Still Very Effective Against This Coronavirus Variant

Pfizer Vaccine Still Very Effective Against This Coronavirus Variant

Share on Pinterest Waldo Swiegers/Bloomberg via Getty Images The coronavirus variant first detected in South Africa may overcome some of the protection the Pfizer-BioNTech vaccine offers, but infections in vaccinated people are still rare. However, the authors point out that in spite of this ability, the rate of this variant in Israel remains very low. So, very few people fully vaccinated with this vaccine will contract the coronavirus. Variants ‘break through’ partial vaccine protection The Israeli researchers found that most of the infections in vaccinated people were due to the B.1.1.7 variant, which is the dominant variant in the country. It’s also possible that the B.1.1.7 variant — which has a high transmission rate — may outcompete B.1.351, they added.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!